國際產業動態
《大師觀點》飛利浦面對AI和醫療創新如何協助數位化轉型?
2019-10-25

AI Empowering the Value and Future of Healthcare

 

Jyh-Ching Yaur

VP & Head of Research and Innovation Hub Shanghai, Philips Greater China

 

Healthcare innovation has been through fast-paced revolutions across the globe. It is a prevailing fact that most healthcare companies are undertaking unprecedented digital transformation journey by adopting all-encompassing digital methodologies and programs. Ubiquitous devices premised on Internet fuels the generation of colossal every day, every moment. However, more data doesn’t equal to more insight. People are drowning in data but lack of insights. That is where Artificial Intelligence can help. Machine learning and deep learning can help to make sense of this data and turn into actionable insights.

At Philips, we envision the AI as Adaptive Intelligence, creating value in clinical pathway and healthy living products by integrating with real context combining other technologies, in an aim to support the quadruple aim of better health outcomes, improved patient experience, improved staff experience, and lower cost of care.

The keynote speech will layout insights from three dimensions:

  1. Digital transformation in healthcare innovation landscape
  • Overall background of digital transformation and AI reasoning in Healthcare industry
  • Landscape in globe, mainland China and Taiwan
  1. Everyone is talking about AI
  • Adaptive intelligence in Philips’s narratives
  • Unlocking the value to realize AI in clinical pathway
  • Leading technologies of Philips (ISD, Digital Twins…)
  1. AI ecosystem innovation methodology – open platform and cocoreation

 

台灣醫療科技展今年邀請到飛利浦 姚智清副總裁蒞臨,將於2019亞洲醫療創新論壇(Med x Tech Summit Asia)暢談全球智慧醫療戰略布局與商機

  更多論壇資訊  

 

 

本網站中所有資料(包括圖檔及文字檔),著作權皆屬本會所有(除另有註明者,或本會網站連結至外部之網站除外),如有引用,請確實註明出處來源。<完整資訊>
© 2024 Institute for Biotechnology and Medicine Industry (IBMI) All rights reserved.
地址:115 台北市南港區忠孝東路七段508號9樓 電話:(02)2655-8168 傳真:(02)2655-7978